Taiwan FDA registration 6a4f1fef51527362e6ab4d93ed78cf0d
"Newxin" ovulation (urine) test group (unsterilized)
TW: "紐新" 排卵(尿液)測試組(未滅菌)
Taiwan·Risk Class 1·NEWSCEN COAST BIO-PHARMACEUTICAL CO., LTD·Registered Apr 02, 2013 – Apr 02, 2018CancelledRegistration details
- Analysis ID
- 6a4f1fef51527362e6ab4d93ed78cf0d
- Customs Code
- DHA04600186802
Company information
- Manufacturer
- NEWSCEN COAST BIO-PHARMACEUTICAL CO., LTD
- Manufacturer Country
- China
- Authorized Representative
- QUANG-YANG CORPORATION
Product details
- Intended Use
- Limited to the first level identification range of the "luteinizing hormone test system (A.1485)" of the Measures for the Administration of Medical Equipment.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1485 Progesterone testing system
- Import Information
- Chinese goods;; input
Dates and status
- Registration Date
- Apr 02, 2013
- Expiry Date
- Apr 02, 2018
- Cancellation Date
- Nov 04, 2019
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Newxin" ovulation (urine) test group (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 6a4f1fef51527362e6ab4d93ed78cf0d and manufactured by NEWSCEN COAST BIO-PHARMACEUTICAL CO., LTD. The authorized representative in Taiwan is QUANG-YANG CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices